Sargent Bickham Lagudis’s NxStage Medical Inc. NXTM Stock Holding History

Sargent Bickham Lagudis’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-120	Closed	-$3K	–	861
2018 Q4	$3K	Hold	120	–	–	﹤0.01%	705
2018 Q3	$3K	Hold	120	–	–	﹤0.01%	728
2018 Q2	$3K	Hold	120	–	–	﹤0.01%	711
2018 Q1	$3K	Hold	120	–	–	﹤0.01%	716
2017 Q4	$3K	Hold	120	–	–	﹤0.01%	742
2017 Q3	$3K	Hold	120	–	–	﹤0.01%	752
2017 Q2	$3K	Hold	120	–	–	﹤0.01%	705
2017 Q1	$3K	Hold	120	–	–	﹤0.01%	690
2016 Q4	$3K	Hold	120	–	–	﹤0.01%	663
2016 Q3	$3	Hold	120	–	–	﹤0.01%	671
2016 Q2	$3K	Hold	120	–	–	﹤0.01%	653
2016 Q1	$2K	Buy	+120	New	+$2.01K	﹤0.01%	687

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Sargent Bickham Lagudis's NXTM Position: Q1 2019 in Review

Sargent Bickham Lagudis sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 120 shares — an estimated $3K sold.

Sargent Bickham Lagudis first reported a position in NXTM in Q1 2016 and held it in 12 quarters. The position peaked at $3K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Sargent Bickham Lagudis reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Sargent Bickham Lagudis sold 120 NxStage Medical Inc. shares in Q1 2019, an estimated $3K.
Sargent Bickham Lagudis first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 12 quarters.
Sargent Bickham Lagudis's NxStage Medical Inc. position peaked at $3K in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Sargent Bickham Lagudis's 13F filing for Q1 2019, filed 13 Sep 2021.